2009
DOI: 10.1016/j.biochi.2008.04.006
|View full text |Cite
|
Sign up to set email alerts
|

Effect of lactoferrin on enteric pathogens

Abstract: Much has been learned in recent years about the mechanisms by which breastfeeding improves child health and survival. However, there has been little progress in using these insights to improve pediatric care. Factors that are important for protecting the breast fed infant might be expected to decrease the adverse effects of weaning on diarrhea, growth, and development. Lactoferrin, an ironbinding protein with multiple physiological functions (anti-microbial, anti-inflammatory, and immunomodulatory), is one of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
93
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 114 publications
(95 citation statements)
references
References 56 publications
2
93
0
Order By: Relevance
“…Additionally, more virulence EAEC genes detected corresponded to a rise in the fecal lactoferrin level ( Table 6 ). The protective function of lactoferrin on infections with enteropathogens have been acknowledged, 56 and colonization/infection, particularly by EAEC in the current study probably contributed to the high lactoferrin levels ( Table 6 ).…”
mentioning
confidence: 68%
“…Additionally, more virulence EAEC genes detected corresponded to a rise in the fecal lactoferrin level ( Table 6 ). The protective function of lactoferrin on infections with enteropathogens have been acknowledged, 56 and colonization/infection, particularly by EAEC in the current study probably contributed to the high lactoferrin levels ( Table 6 ).…”
mentioning
confidence: 68%
“…As reviewed in reference 670, in a vaccine study using the ETEC heat-labile toxin, the rate of infection and severity of disease caused by ETEC was decreased, and despite the presence of EAEC in the placebo groups, the vaccine-treated group had no EAEC detected, suggesting that the vaccine may also exert protection against EAEC (687). In vitro treatment with lactoferrin inhibits EAEC enteroadhesion and biofilm formation, making it a potential but untested nonantibiotic treatment for the prevention of EAEC (670,688).…”
Section: Clinical Considerationsmentioning
confidence: 99%
“…The inhibitory action of camel milk against L. monocytogenes, S. aureus and E. coli has been attributed to the presence of lactoperoxidase, hydrogen peroxide and lysozyme, respectively. The growth of Salmonella typhimurium is inhibited by lactoferrin in camel milk through binding iron and making it unavailable for its growth [26,84]. It is demonstrated that the potential for camel lactoferrin to inhibit HCV entry into human leukocytes is with more efficiency than human or bovine lactoferrin [31].…”
Section: Antibacterial Activitymentioning
confidence: 99%